Ensign Peak Advisors’s Molecular Templates, Inc. MTEM Stock Holding History

Ensign Peak Advisors’s Portfolio MTEM Stock Details MTEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-9,384	Closed	-$486K	–	2226
2022 Q1	$486K	Hold	9,384	–	–	﹤0.01%	1559
2021 Q4	$552K	Buy	9,384 +2,365	+34%	+$177K	﹤0.01%	1593
2021 Q3	$706K	Buy	+7,019	New	+$724K	﹤0.01%	1544
2020 Q4	–	Sell	-1,547	Closed	-$253K	–	1888
2020 Q3	$253K	Buy	+1,547	New	+$275K	﹤0.01%	1646
2020 Q1	–	Sell	-1,168	Closed	-$245K	–	1701
2019 Q4	$245K	Buy	+1,168	New	+$168K	﹤0.01%	1612

Other funds holding MTEM

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ensign Peak Advisors's MTEM Position: Q2 2022 in Review

Ensign Peak Advisors sold out of Molecular Templates, Inc. (MTEM) in Q2 2022, closing a stake of 9,384 shares — an estimated $486K sold.

Ensign Peak Advisors first reported a position in MTEM in Q4 2019 and held it in 5 quarters. The position peaked at $706K in Q3 2021. 65 funds tracked by Wall St. Rank hold MTEM as of Q2 2022.

Ensign Peak Advisors reported no remaining Molecular Templates, Inc. position as of Q2 2022 after selling out during the quarter.
Ensign Peak Advisors sold 9,384 Molecular Templates, Inc. shares in Q2 2022, an estimated $486K.
Ensign Peak Advisors first reported a position in Molecular Templates, Inc. in Q4 2019 and held it in 5 quarters.
Ensign Peak Advisors's Molecular Templates, Inc. position peaked at $706K in Q3 2021.
65 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q2 2022.

Based on Ensign Peak Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.